The effect of antimalarials on the safety and persistence of treatment with biologic agents or JAK inhibitors in rheumatoid arthritis.
Markus BredemeierÂngela L DuarteMarcelo M PinheiroBárbara S KahlowJosé C MacieiraRoberto RanzaJosé R MirandaValéria ValimGláucio R de CastroManoel B BértoloMaria F SaumaVander FernandesAna C RibeiroReginaldo B TeodoroClaiton V BrenolHellen M CarvalhoSâmia A StudartGeraldo R PinheiroLaurindo F da RochaHugo D de LimaIvânio A PereiraMorgana O GazzetaAdriana M KakehasiPaulo LouzadaAndré L HayataCristiano M LupoInês G da SilveiraSergio C KowalskiDavid C TittonRafael M ChakrAline RanzolinRicardo M XavierIeda M Laurindonull nullPublished in: Rheumatology (Oxford, England) (2023)
Among RA patients on treatment with bDMARDs or JAKi, concomitant use of antimalarials was associated with reduced the incidence of serious and total AEs and with longer treatment course survival.